Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide is a temperature-sensitive biological molecule, and the licensed guidance is precise about why: once the peptide degrades, it cannot be detected by sight, smell or feel — a compromised pen looks identical to an intact one. Tirzepatide's stability under real-world storage conditions is well-characterised in the clinical data underpinning Mounjaro's UK licence, and the principles are worth understanding before your first pen arrives. As a prescription-only medicine, Mounjaro is dispensed through a GPhC-registered pharmacy only after a prescriber assesses whether it is clinically suitable for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide belongs to a class of medicines built from amino-acid chains (peptides) that mimic the body's own gut hormones GIP and GLP-1. The clinical programme that led to Mounjaro's UK licence, including the SURMOUNT-1 study published in the New England Journal of Medicine, used medication that had been manufactured, stored and distributed under tightly controlled cold-chain conditions. That context matters: the efficacy data reflects the drug as it was intended to reach the patient.
Peptide bonds are susceptible to hydrolysis and oxidation when exposed to elevated temperatures, repeated freeze-thaw cycles, or prolonged ultraviolet light. None of those processes produce a visible change to the solution. The liquid in the KwikPen stays clear and colourless whether the peptide is fully active or partially degraded, there is no colour shift, no cloudiness, no odour to alert you. This is the core reason the temperature stability requirements for tirzepatide are framed as absolute rules rather than guidelines.
The Mounjaro SmPC, published on the eMC (Electronic Medicines Compendium), sets out the formal stability data from Eli Lilly's pharmaceutical testing. That document is the authoritative reference for storage conditions, and any question about an edge case (a delay in transit, a fridge that malfunctioned) should be directed to your prescriber or pharmacist rather than resolved by eye-check alone.
The baseline rule is straightforward: store the KwikPen in a refrigerator at 2°C to 8°C, away from the freezer compartment and the back wall where temperatures can drop below zero. Many domestic fridges have cold spots, the fridge door shelf, away from the main cooling element, is a practical location for most households, though individual appliances vary.
Once the pen is brought to room temperature for use, a time-limited window applies before it must be used or discarded. The precise duration of that window is stated in the Patient Information Leaflet that comes with every pack; it differs from other GLP-1 medicines and should not be assumed from memory or from information about a different product. How tirzepatide dissolves and behaves in solution depends on the formulation staying within its validated conditions throughout this period.
One practical habit worth building: before each weekly injection, check the pen's expiry date and confirm it has been stored correctly since the last use. That check takes under a minute and catches the most common real-world stability risks before they reach the injection stage. Never use a pen that has been frozen, even if it has since thawed and looks normal, freezing disrupts the formulation in ways that cannot be reversed or assessed without laboratory analysis.
Heat is the primary threat. Leaving a pen in a car on a warm day, placing it near a radiator, or carrying it in luggage stored in a hold with uncontrolled temperature can all take the pen outside its validated range. The NHS guidance on weight-management injections advises patients to plan travel with temperature-sensitive medicines in mind, and this applies directly to Mounjaro.
Freezing is equally damaging and perhaps more commonly accidental, a pen stored near the back of a fan-assisted fridge or in a fridge set colder than typical can freeze without the user noticing. Check your fridge thermometer if you are unsure; a cheap appliance thermometer is a worthwhile purchase for anyone on long-term refrigerated medication.
Light exposure across the storage period is a secondary concern. The pen's opaque casing provides some protection, but the SmPC advises keeping it out of direct sunlight. This is less a short-term risk (the few seconds of light during injection preparation are irrelevant) and more relevant to storage over days or weeks in a bright location.
Mechanical damage matters too. Dropping the pen or subjecting the cartridge to physical shock is not purely a delivery problem; if the cartridge cracks or the auto-injection mechanism is compromised, the pen should not be used. Contact your pharmacy for guidance on replacement.
Do not inject a pen you have doubts about. The risk is not that the medicine becomes dangerous in the way a contaminated food might, rather, a destabilised peptide is simply inactive, meaning you would receive no therapeutic benefit while continuing to experience whatever side effects the remaining active compound produces. That is a poor trade-off.
If a delivery has been delayed significantly, if your fridge failed, or if a pen was accidentally left at room temperature for longer than the leaflet allows, contact your pharmacy. At nume, our prescribers and pharmacy team are reachable seven days a week through our support line, and pen-storage questions are exactly the sort of aftercare query we handle routinely. Replacement guidance depends on how long and how far outside conditions the pen travelled, your pharmacist can help you decide.
For anyone still researching whether tirzepatide is right for them, the full Mounjaro overview covers how the medicine works, what to expect from treatment and how the private route works in practice. If you want to understand how treatment pricing works alongside all the other factors, the cost context for Mounjaro in the UK sets that out plainly. When you are ready, checking your eligibility with our prescribers is the next step, and if stock is a concern at any point, you can also check current Mounjaro availability before committing to a plan.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.